- Title
- Prescription Drug Affordability Board - Authority and Stakeholder Council Membership (Lowering Prescription Drug Costs for All Marylanders Now Act)
- Sponsored by
- Delegates Cullison, White Holland, Alston, Bagnall, Bhandari, Guzzone, Hill, S. Johnson, Kaiser, Kerr, Lopez, Martinez, Pena-Melnyk, Rosenberg, Taveras, Woods, and Woorman
- Status
- In the House - Passed Enrolled
- Analysis
- Fiscal and Policy Note (Revised)
Synopsis
Altering the membership of the Prescription Drug Affordability Stakeholder Council; requiring the Prescription Drug Affordability Board, under certain circumstances, to establish a process for setting upper payment limits for purchases and payor reimbursements of prescription drug products that the Board determines have led or will lead to affordability challenges; authorizing the Board to reconsider an upper payment limit for a drug that becomes a current shortage; and altering requirements related to the setting of upper payment limits.
Committees
- Opposite:
- Finance
Committee Testimony
Details
Cross-filed with: SB0357
Bill File Type: Regular
Effective Date(s): October 1, 2025
Contingency - on a contingency described in Sec. 3 of the bill
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
Last Updated: 4/14/2025 9:04 AM
MyMGA
Accessibility Tools